[Federal Register Volume 61, Number 78 (Monday, April 22, 1996)]
[Notices]
[Page 17705]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-9778]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Findings of Scientific Misconduct
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the Office of Research Integrity
(ORI) has made final findings of scientific misconduct in the following
case:
Joan Gans, R.N., Denver Department of Health and Hospitals: Based
on an audit of records conducted by the National Institute of Allergy
and Infectious Diseases (NIAID) and Ms. Gans admission, ORI found that
Joan Gans, R.N., while employed at the Denver Community Program for
Clinical Research on AIDS at the Department of Public Health, Denver
Department of Health and Hospitals, committed scientific misconduct by
falsifying and fabricating data related to patients entered on clinical
trials. The research was supported by a NIAID contract.
Ms. Gans has entered into a Voluntary Exclusion Agreement with ORI
in which she has voluntarily agreed:
(1) To exclude herself from any contracting or subcontracting with
any agency of the United States Government and from eligibility for, or
involvement in, nonprocurement transactions (e.g., grants and
cooperative agreements) of the United States Government, as defined in
45 CFR Part 76 (Debarment Regulations) for a period of two (2) years
beginning April 4, 1996;
(2) That for a period of one (1) year immediately following the two
(2) year voluntary exclusion above, any institution that submits an
application for Public Health Service (PHS) support for a research
project on which Ms. Gans' participation is proposed or that uses her
in any capacity in PHS supported research must concurrently submit a
plan for supervision of her duties; the supervisory plan must be
designed to ensure the scientific integrity of Ms. Gans' research
contribution, and the institution must submit a copy of the plan to
ORI; and
(3) To exclude herself from serving in any advisory capacity to
PHS, including but not limited to service on any PHS advisory
committee, board, and/or peer review committee, or as a consultant for
a period of three (3) years beginning April 4, 1996.
The above voluntary exclusion, however, shall not apply to Ms.
Gans' future training or practice of clinical nursing whether as a
nursing student, resident, fellow, or licensed nurse, as the case may
be, unless that practice involves research or research training.
No scientific publications were required to be corrected as part of
this Agreement. The questioned data will be excluded before any
findings of the affected clinical trials are reported.
FOR FURTHER INFORMATION CONTACT: Director, Division of Research
Investigations, Office of Research Integrity, 5515 Security Lane, Suite
700, Rockville, MD 20852.
Chris B. Pascal,
Acting Director, Office of Research Integrity.
[FR Doc. 96-9778 Filed 4-19-96; 8:45 am]
BILLING CODE 4160-17-P
